BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines

CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available...

October 26, 2022 | News

U.S. FDA Grants EUA for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

October 24, 2022 | News

Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants

Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the...

October 13, 2022 | News

Roche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75

Roche (SIX: RO, ROG;OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed a COVID-19 test for researchers that detects and differentiates ...

August 22, 2022 | News

Seegene launches the world's first in-life PCR campaign in Vietnam

Seegene's in-life PCR campaign is a global initiative designed to encourage regular testing for respiratory viruses, including COVID-19, flu and ...

August 17, 2022 | News

Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya

The NPHL operates under Kenya's Ministry of Health and plays an important role in the nation's healthcare by providing reference testing for key ...

August 04, 2022 | News

Persistent Loss of Smell Due to Covid-19 Closely Connected to Long-Lasting Cognitive Problems

Also, ICU Stay May Double Risk of Dementia in Older Adults SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- New insights into factors that may...

August 01, 2022 | News

Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy

Independent lab results demonstrate that the combination therapy retains neutralizing activity against currently dominant COVID-19 strains, as previously d...

July 27, 2022 | News

Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The ...

July 20, 2022 | News

Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea

SK bioscience and GSK recently announced the successful authorization:SK bioscience announced that 'SKYCovione(TM),' South Korea's first COVID-19 vaccine c...

July 14, 2022 | News

U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

July 12, 2022 | News

Australian developed VIRALEZE™ nasal spray relaunched by LloydsPharmacy in the UK

Extensive antiviral testing undertaken at the globally renowned Scripps Research Institute in the United States show that VIRALEZE&trad...

July 01, 2022 | News

GSK Spreads Awareness on Vaccine-Preventable Diseases, Attempting to Bridge the Vaccination Gap in Malaysia

GSK is a science-led global healthcare company, delivering vaccines that help protect people at all stages of life. GSK's new purpose is to unite science, ...

July 01, 2022 | News

Mesh Bio and MultiOmic Health partner to advance precision medicines and diagnostics for chronic metabolic disease in Asia with AI

Mesh will collaborate with its network of healthcare provider customers to recruit patients for the study. MultiOmic will generate genomic, proteomic, meta...

June 30, 2022 | News

Stay Connected